Financial Statements — CRESY
Balance Sheet
(in billions ARS)| Metric | FY
2025 | FY
2024 | FY
2023 | FY
2022 | FY
2021 | FY
2020 | FY
2019 |
|---|
| Cash & Equivalents | 250.86 | 114.64 | 38.94 | 34.91 | 27.53 | 100.93 | 62.48 |
| Total Current Assets | 1,246.70 | 706.40 | 214.94 | 112.99 | 69.98 | 231.02 | 153.06 |
| Total Assets | 5,088.82 | 3,473.11 | 1,069.35 | 529.23 | 339.17 | 686.94 | 507.99 |
| Total Current Liabilities | 1,001.78 | 657.61 | 195.02 | 147.58 | 70.43 | 172.86 | 89.60 |
| Total Liabilities | 2,875.03 | 1,909.20 | 586.33 | 322.44 | 233.28 | 564.79 | 418.99 |
| Retained Earnings | -- | -- | -- | -- | 1.16 | -- | -- |
| Total Stockholder Equity* | 2,213.79 | 1,563.91 | 483.03 | 206.79 | 105.89 | 122.15 | 89.00 |
* Derived from reported values
Income Statement
(in billions ARS) (except per-share rows)| Metric | FY
2025 | FY
2024 | FY
2023 | FY
2022 | FY
2021 | FY
2020 | FY
2019 |
|---|
| Total Revenue | 914.16 | 711.37 | 190.41 | 95.85 | 42.41 | 121.26 | 82.67 |
| Cost of Revenue* | 546.10 | 419.82 | 119.13 | 53.39 | 19.95 | 80.49 | 51.61 |
| Total Operating Expenses | -- | -- | -- | 69.79 | 33.83 | 83.97 | (53.19) |
| Operating Income | -- | -- | -- | 43.23 | 9.92 | 44.07 | (9.81) |
| Interest Expense | -- | -- | -- | -- | 14.21 | 24.36 | 17.01 |
| Net Income | 224.37 | 93.98 | 78.18 | 63.00 | (24.50) | 20.00 | (28.50) |
| Diluted EPS | -- | -- | -- | -- | -- | (7.63) | (38.34) |
* Derived from reported values
Cash Flow Statement
(in billions ARS)| Metric | FY
2025 | FY
2024 | FY
2023 | FY
2022 | FY
2020 | FY
2019 |
|---|
| Operating Cash Flow | 151.32 | 68.61 | 35.97 | 21.81 | 35.73 | 17.87 |
| Investing Cash Flow | (80.56) | 92.57 | 14.92 | 12.89 | 40.31 | 7.38 |
| Financing Cash Flow | 86.18 | (208.53) | (90.74) | (37.02) | (72.62) | (18.01) |
